Zacks Investment Research upgraded shares of Imperva (NASDAQ:IMPV) from a hold rating to a strong-buy rating in a report published on Friday, February 16th. Zacks Investment Research currently has $53.00 target price on the software maker’s stock.
According to Zacks, “Imperva Inc. is engaged in the development of protection software and services for business applications and databases. The Company delivers innovative technology to give full audit accountability and separation of duties to meet regulatory compliance. It offers SecureSphere Data Security Suite to protect sensitive data from hackers and malicious insiders along with providing a fast and cost-effective route to regulatory compliance and establishes a repeatable process for data risk management. The Company’s SecureSphere offers database security solutions to secure sensitive data stored in databases, File Security solutions to protect sensitive files on file servers, storage devices, content repositories, and meet regulatory compliance mandates and Web Application Security solutions to protect web applications from cyber attacks. Imperva Inc. is headquartered in Redwood Shores, California. “
Several other research firms also recently weighed in on IMPV. KeyCorp reissued a hold rating on shares of Imperva in a research report on Tuesday, October 24th. ValuEngine raised Imperva from a sell rating to a hold rating in a research report on Thursday, February 15th. Piper Jaffray Companies upgraded Imperva from a neutral rating to an overweight rating and set a $52.00 price objective for the company in a report on Friday, February 9th. Oppenheimer restated a buy rating and set a $55.00 price objective on shares of Imperva in a report on Thursday, November 9th. Finally, Evercore ISI restated a buy rating and set a $56.00 price objective on shares of Imperva in a report on Wednesday, November 8th. Three analysts have rated the stock with a sell rating, four have given a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the company. The stock presently has a consensus rating of Buy and an average price target of $53.14.
Imperva (NASDAQ:IMPV) last issued its earnings results on Thursday, February 8th. The software maker reported $0.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.27 by $0.13. Imperva had a negative return on equity of 3.28% and a net margin of 7.11%. The company had revenue of $91.10 million for the quarter, compared to the consensus estimate of $91.11 million. During the same quarter last year, the company earned $0.32 EPS. The firm’s quarterly revenue was up 16.2% on a year-over-year basis. sell-side analysts anticipate that Imperva will post -0.17 EPS for the current fiscal year.
In other news, Director Anthony J. Bettencourt sold 66,037 shares of the company’s stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $46.98, for a total value of $3,102,418.26. Following the sale, the director now owns 66,037 shares in the company, valued at $3,102,418.26. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CRO Michael D. Mooney sold 24,454 shares of the company’s stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $47.18, for a total value of $1,153,739.72. Following the completion of the sale, the executive now owns 24,454 shares in the company, valued at approximately $1,153,739.72. The disclosure for this sale can be found here. 1.90% of the stock is currently owned by corporate insiders.
Several institutional investors and hedge funds have recently modified their holdings of the company. Nationwide Fund Advisors boosted its position in Imperva by 13.8% during the second quarter. Nationwide Fund Advisors now owns 19,007 shares of the software maker’s stock worth $909,000 after purchasing an additional 2,305 shares in the last quarter. BlackRock Inc. boosted its position in Imperva by 11.3% during the second quarter. BlackRock Inc. now owns 2,124,043 shares of the software maker’s stock worth $101,635,000 after purchasing an additional 215,170 shares in the last quarter. New York State Common Retirement Fund boosted its position in Imperva by 5.3% during the second quarter. New York State Common Retirement Fund now owns 35,800 shares of the software maker’s stock worth $1,713,000 after purchasing an additional 1,793 shares in the last quarter. Northern Trust Corp boosted its position in Imperva by 10.3% during the second quarter. Northern Trust Corp now owns 435,986 shares of the software maker’s stock worth $20,861,000 after purchasing an additional 40,778 shares in the last quarter. Finally, Vanguard Group Inc. boosted its position in Imperva by 4.3% during the second quarter. Vanguard Group Inc. now owns 2,439,240 shares of the software maker’s stock worth $116,718,000 after purchasing an additional 99,799 shares in the last quarter.
Imperva Company Profile
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.